Jump to Main Content
B-cell receptor activation inhibits AID expression through calmodulin inhibition of E-proteins
- Hauser, Jannek, Sveshnikova, Natalia, Wallenius, Anders, Baradaran, Sanna, Saarikettu, Juha, Grundström, Thomas
- Proceedings of the National Academy of Sciences of the United States of America 2008 v.105 no.4 pp. 1267-1272
- B-lymphocytes, DNA, antibodies, antibody affinity, antigens, binding sites, calcium, calmodulin, cytidine deaminase, exons, gene overexpression, genes, mutagenicity, point mutation, transcription factors
- Upon encountering antigens, B-lymphocytes can adapt to produce a highly specific and potent antibody response. Somatic hypermutation, which introduces point mutations in the variable regions of antibody genes, can increase the affinity for antigen, and antibody effector functions can be altered by class switch recombination (CSR), which changes the expressed constant region exons. Activation-induced cytidine deaminase (AID) is the mutagenic antibody diversification enzyme that is essential for both somatic hypermutation and CSR. The mutagenic AID enzyme has to be tightly controlled. Here, we show that engagement of the membrane-bound antibodies of the B-cell receptor (BCR), which signals that good antibody affinity has been reached, inhibits AID gene expression and that calcium (Ca²⁺) signaling is essential for this inhibition. Moreover, we show that overexpression of the Ca²⁺ sensor protein calmodulin inhibits AID gene expression, and that the transcription factor E2A is required for regulation of the AID gene by the BCR. E2A mutated in the binding site for calmodulin, and thus showing calmodulin-resistant DNA binding, makes AID expression resistant to the inhibition through BCR activation. Thus, BCR activation inhibits AID gene expression through Ca²⁺/calmodulin inhibition of E2A.